NCT02939209View on ClinicalTrials.gov

Pre-emptive Opioid Treatment to Prevent Rebound Pain After Arthroscopic Rotator Cuff Repair and/or Acromioplasty Under General Anesthesia and Interscalene Block

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Rotator Cuff InjuryPain
Interventions
DRUG

Hydromorphone Hcl 2Mg Tab

Patients will be given 2 mg hydromorphone (immediate release formulation) in the post anesthetic care unit.

DRUG

Placebo

Patients may be randomized to placebo.

Trial Locations (2)

B3H1V8

Nova Scotia Health Authority Queen Elizabeth II Hospital Halifax Infirmary site, Halifax

L8S4K1

St Joseph's (McMaster University), Hamilton

All Listed Sponsors
lead

Vishal Uppal

OTHER

NCT02939209 - Pre-emptive Opioid Treatment to Prevent Rebound Pain After Arthroscopic Rotator Cuff Repair and/or Acromioplasty Under General Anesthesia and Interscalene Block | Biotech Hunter | Biotech Hunter